Insomnia Disorder Among Coronavirus Disease Survivors: A South Korean Nationwide Cohort Study
Open Access
- 25 November 2021
- journal article
- research article
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 18 (11), 1082-1090
- https://doi.org/10.30773/pi.2021.0223
Abstract
Objective We investigated the prevalence and associated factors of insomnia disorder among survivors of coronavirus disease of 2019 (COVID-19). Methods This population-based cohort study used data from the National Health Insurance Service COVID-19 cohort database from January 1 to June 4, 2020. COVID-19 patients were defined as individuals whose test confirmed that they were infected, regardless of the severity, and survivors were defined as individuals who recovered from the infection. Results A total of 299,968 individuals were included in the final analysis, and 6,934 were considered as COVID-19 survivors, while the control group comprised 292,764 individuals. In the multivariable model after covariate adjustment, COVID-19 survivors had a 3.33-fold higher prevalence of insomnia disorder than the control group (odds ratio [OR]: 3.33, 95% confidence interval [CI]: 2.98-3.73; p<0.001). In the sensitivity analysis, the COVID-19 survivors with no specific treatment and the survivors with specific treatment were associated with a 3.16-fold (OR: 3.16, 95% CI: 2.77-3.59; p<0.001) and 3.89-fold (OR: 3.89, 95% CI: 3.17-4.78; p<0.001) higher prevalence of insomnia disorder than the control group. Conclusion In South Korea, 5.4% of COVID-19 survivors were diagnosed with insomnia disorder at 6 months follow-up. Thus, insomnia disorder is a public health issue for COVID-19 survivors. Psychiatry Investig 2021;18(11):1082-1090Keywords
Funding Information
- Patient-Centered Clinical Research Coordinating Center
- Ministry of Health and Welfare (HI19C0481, HC20C0013)
This publication has 39 references indexed in Scilit:
- Psychosocial factors are strongly associated with insomnia in users and nonusers of prescribed sleep medication: evidence from the HUNT3 studyJournal of Multidisciplinary Healthcare, 2016
- InsomniaJAMA, 2013
- Insomnia in central neurologic diseases – Occurrence and managementSleep Medicine Reviews, 2011
- Nighttime Insomnia Symptoms and Perceived Health in the America Insomnia Survey (AIS)Sleep, 2011
- Sleep loss and inflammationBest Practice & Research Clinical Endocrinology & Metabolism, 2010
- Reduced Brain GABA in Primary Insomnia: Preliminary Data from 4T Proton Magnetic Resonance Spectroscopy (1H-MRS)Sleep, 2008
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational StudiesAnnals of Internal Medicine, 2007
- On informative detection bias in screening studiesStatistics in Medicine, 2007
- GABAAReceptors in Central Nervous System Disease: Anxiety, Epilepsy, and InsomniaJournal of Receptors and Signal Transduction, 2006
- Depression and unemployment: Panel findings from the Epidemiologic Catchment Area studyAmerican Journal of Community Psychology, 1994